- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Healthpeak Properties Stock Rating Upgraded by Wall Street Zen
Analysts raise rating from 'sell' to 'hold' for the healthcare real estate investment trust.
Feb. 9, 2026 at 1:55am
Got story updates? Submit your updates here. ›
Healthpeak Properties (NYSE:DOC), a real estate investment trust focused on healthcare properties, has been upgraded by analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a new research note. Several other research firms have also recently commented on Healthpeak, with some adjusting their price targets and ratings.
Why it matters
As a major REIT in the healthcare real estate sector, Healthpeak's stock performance and analyst ratings are closely watched by investors. This upgrade from a 'sell' to a 'hold' rating could signal a shift in sentiment around the company's prospects, though it remains rated as a 'Hold' overall by analysts.
The details
The Wall Street Zen upgrade comes after other recent rating changes for Healthpeak. Robert W. Baird cut their target price on Healthpeak shares from $21 to $20 and maintained an 'outperform' rating, while Argus downgraded the stock from 'buy' to 'hold'. Cantor Fitzgerald began coverage with a 'neutral' rating and $17 price target, and Weiss Ratings raised their rating from 'sell (d+)' to 'hold (c-)'.
- The Wall Street Zen upgrade was issued on Saturday, February 9, 2026.
- Healthpeak reported its latest quarterly earnings on Monday, February 2, 2026.
The players
Healthpeak Properties
A real estate investment trust (REIT) that specializes in healthcare-related real estate, including life science research facilities, medical office buildings, and senior housing communities.
Wall Street Zen
A financial research and analysis firm that covers Healthpeak Properties and other stocks.
Robert W. Baird
An investment banking and asset management firm that covers Healthpeak Properties.
Cantor Fitzgerald
A global financial services firm that initiated coverage on Healthpeak Properties.
Argus
An independent research firm that downgraded Healthpeak Properties from 'buy' to 'hold'.
Weiss Ratings
A financial research firm that upgraded Healthpeak Properties from 'sell (d+)' to 'hold (c-)'.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident
“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”
— Gordon Edgar, grocery employee
The takeaway
This rating upgrade for Healthpeak Properties, while still maintaining an overall 'Hold' consensus, suggests that analysts see some potential upside in the healthcare REIT's stock despite recent headwinds. Investors will be watching closely to see if the company can capitalize on its diversified portfolio of life science, medical office, and senior housing properties.
Irvine top stories
Irvine events
Mar. 19, 2026
Anthony JeselnikMar. 19, 2026
Anthony Jeselnik



